John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
TransUnion
TRU
$16.2B
| $26.6M | 0.08% |
371,760
-39,116
| -10% | -$2.61M |
|
327
UGI
UGI
$8.06B
| $26.4M | 0.08% |
506,041
+251,815
| +99% | +$12.2M |
|
|
CADE
328
DELISTED
Cadence Bancorporation
CADE
| $26.3M | 0.08% |
911,733
+514,374
| +129% | +$15M |
|
329
Ameriprise Financial
AMP
$49.1B
| $26.3M | 0.08% |
+187,753
| New | +$26.6M |
|
|
DISH
330
DELISTED
DISH Network Corp.
DISH
| $26.2M | 0.08% |
778,261
-261,235
| -25% | -$8.91M |
|
|
UN
331
DELISTED
Unilever NV New York Registry Shares
UN
| $26.1M | 0.08% |
468,662
+217,421
| +87% | +$12.2M |
|
332
Atlassian
TEAM
$43.5B
| $25.9M | 0.08% |
413,909
+59,558
| +17% | +$3.66M |
|
333
American Eagle Outfitters
AEO
$2.71B
| $25.9M | 0.08% |
1,112,654
+1,083,699
| +3,743% | +$24M |
|
|
CELG
334
PUT
DELISTED
Celgene Corp
CELG
| $25.9M | 0.08% |
325,500
+225,100
| +224% | +$18.7M |
|
335
Delta Air Lines
DAL
$54.2B
| $25.8M | 0.08% |
520,180
-1,305,325
| -72% | -$69.6M |
|
|
CSOD
336
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $25.7M | 0.08% |
541,815
+409,851
| +311% | +$19.1M |
|
337
CALL
RTX Corp
RTX
$283B
| $25.6M | 0.08% |
+325,904
| New | +$25.5M |
|
338
Alexandria Real Estate Equities
ARE
$9.21B
| $25.6M | 0.08% |
202,535
+167,542
| +479% | +$20.9M |
|
|
CHL
339
DELISTED
China Mobile Limited
CHL
| $25.3M | 0.08% |
569,389
-88,906
| -14% | -$4.09M |
|
|
CA
340
DELISTED
CA, Inc.
CA
| $25.2M | 0.08% |
705,667
+323,731
| +85% | +$11.4M |
|
|
341
CALL
Meta Platforms (Facebook)
META
$1.4T
| $25.1M | 0.08% |
129,400
+24,400
| +23% | +$4.41M |
|
342
Cardinal Health
CAH
$53.4B
| $25.1M | 0.07% |
+514,608
| New | +$29.2M |
|
343
Paychex
PAYX
$44.3B
| $25M | 0.07% |
366,441
+271,411
| +286% | +$17.5M |
|
344
Camden Property Trust
CPT
$10.8B
| $24.9M | 0.07% |
273,657
-191,713
| -41% | -$16.7M |
|
345
Abbott
ABT
$202B
| $24.9M | 0.07% |
408,752
+373,337
| +1,054% | +$22.6M |
|
346
UDR
UDR
$12.1B
| $24.8M | 0.07% |
661,543
+374,977
| +131% | +$13.6M |
|
347
Ligand Pharmaceuticals
LGND
$5.71B
| $24.6M | 0.07% |
190,544
-48,981
| -20% | -$5.47M |
|
348
CALL
Intuitive Surgical
ISRG
$134B
| $24.4M | 0.07% |
153,000
+82,500
| +117% | +$12.6M |
|
|
349
PUT
Intuitive Surgical
ISRG
$134B
| $24.4M | 0.07% |
153,000
+89,100
| +139% | +$13.6M |
|
|
WUBA
350
DELISTED
58.com Inc
WUBA
| $24.3M | 0.07% |
351,097
-226,432
| -39% | -$18.5M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.